Cargando…
Can combined use of tumor markers in pancreatic cancer be a solution to short- and long-term consequences?: A retrospective study
As in other types of cancer, tumor markers are used in pancreatic ductal adenocarcinoma (PDAC) for disease follow-up, especially after surgery. There has been shown to be a significant correlation between the tumor marker levels and poor prognosis in locally or systemic advanced stage PDAC patients....
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019147/ https://www.ncbi.nlm.nih.gov/pubmed/36930073 http://dx.doi.org/10.1097/MD.0000000000033325 |